
Reset all filters
01 2Merislon
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 69
2022 Revenue in Millions : 62
Growth (%) : 26
Main Therapeutic Indication : Rare Diseases and Disorders
Currency : USD
2024 Revenue in Millions : 95
2023 Revenue in Millions : 91
Growth (%) : 4